Novel method to measure serum levels of des‐gamma‐carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: A preliminary report
Authors:
Open Access
- 9 February 2012
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 103 (5) , 921-925
Abstract
Des‐gamma‐carboxy prothrombin (DCP) is a useful tumor marker for hepatocellular carcinoma (HCC), but its utility is limited in patients taking vitamin K antagonists. We evaluated the NX‐DCP ratio, a newly developed method to measure serum DCP, for its ability to identify DCP elevation induced by HCC in this patient subpopulation. Conventional DCP measurements and the NX‐DCP ratio were compared in patients with and without HCC, all of whom were taking the vitamin K antagonist warfarin. We found no differences in conventional DCP measurements between patients with and without HCC due to warfarin treatment. In contrast, the NX‐DCP ratio was significantly higher in patients with HCC; the NX‐DCP ratio in all patients without HCC was Cancer Sci 2012; 103: 921–925)Keywords
This publication has 28 references indexed in Scilit:
- Clinical utility of highly sensitive Lens culinaris agglutinin‐reactive alpha‐fetoprotein in hepatocellular carcinoma patients with alpha‐fetoprotein <20 ng/mLCancer Science, 2011
- Automated immunoassay system for AFP–L3% using on-chip electrokinetic reaction and separation by affinity electrophoresisAnalytical Biochemistry, 2009
- High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinomaCancer, 2009
- Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum MarkersClinical Gastroenterology and Hepatology, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Distribution of the heterogeneity of des‐γ‐carboxyprothrombin in patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2005
- γ-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-γ-carboxy prothrombinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984
- Acquired Vitamin K-Dependent Carboxylation Deficiency in Liver DiseaseNew England Journal of Medicine, 1981